Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis.
Authors
Biniecka, MonikaKennedy, Aisling
Ng, Chin T
Chang, Ting C
Balogh, Emese
Fox, Edward
Veale, Douglas J
Fearon, Ursula
O'Sullivan, Jacintha N
Affiliation
Translation Rheumatology Research Group, Dublin Academic Medical Centre, The Conway Institute of Biomolecular and Biomedical Research, St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland.Issue Date
2011MeSH
Arthritis, RheumatoidBiological Agents
Cell Hypoxia
DNA, Mitochondrial
Humans
Immunohistochemistry
Mitochondria
Mutagenesis
Mutation
Oxidative Stress
Oxygen
Reverse Transcriptase Polymerase Chain Reaction
Synovial Membrane
Tumor Necrosis Factor-alpha
Metadata
Show full item recordCitation
Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis. 2011, 13 (4):R121 Arthritis Res. Ther.Journal
Arthritis research & therapyDOI
10.1186/ar3424PubMed ID
21787418Abstract
To examine the effects of tumour necrosis factor (TNF) blocking therapy on the levels of early mitochondrial genome alterations and oxidative stress.Eighteen inflammatory arthritis patients underwent synovial tissue oxygen (tpO(2)) measurements and clinical assessment of disease activity (DAS28-CRP) at baseline (T0) and three months (T3) after starting biologic therapy. Synovial tissue lipid peroxidation (4-HNE), T and B cell specific markers and synovial vascular endothelial growth factor (VEGF) were quantified by immunohistochemistry. Synovial levels of random mitochondrial DNA (mtDNA) mutations were assessed using Random Mutation Capture (RMC) assay.
4-HNE levels pre/post anti TNF-α therapy were inversely correlated with in vivo tpO(2) (P < 0.008; r = -0.60). Biologic therapy responders showed a significantly reduced 4-HNE expression (P < 0.05). High 4-HNE expression correlated with high DAS28-CRP (P = 0.02; r = 0.53), tender joint count for 28 joints (TJC-28) (P = 0.03; r = 0.49), swollen joint count for 28 joints (SJC-28) (P = 0.03; r = 0.50) and visual analogue scale (VAS) (P = 0.04; r = 0.48). Strong positive association was found between the number of 4-HNE positive cells and CD4+ cells (P = 0.04; r = 0.60), CD8+ cells (P = 0.001; r = 0.70), CD20+ cells (P = 0.04; r = 0.68), CD68+ cells (P = 0.04; r = 0.47) and synovial VEGF expression (P = 0.01; r = 063). In patients whose in vivo tpO(2) levels improved post treatment, significant reduction in mtDNA mutations and DAS28-CRP was observed (P < 0.05). In contrast in those patients whose tpO2 levels remained the same or reduced at T3, no significant changes for mtDNA mutations and DAS28-CRP were found.
High levels of synovial oxidative stress and mitochondrial mutation burden are strongly associated with low in vivo oxygen tension and synovial inflammation. Furthermore these significant mitochondrial genome alterations are rescued following successful anti TNF-α treatment.
Language
enISSN
1478-6362Ethical Approval
N/Aae974a485f413a2113503eed53cd6c53
10.1186/ar3424
Scopus Count
Collections
Related articles
- Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis.
- Authors: Biniecka M, Fox E, Gao W, Ng CT, Veale DJ, Fearon U, O'Sullivan J
- Issue date: 2011 Aug
- Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia.
- Authors: Kennedy A, Ng CT, Chang TC, Biniecka M, O'Sullivan JN, Heffernan E, Fearon U, Veale DJ
- Issue date: 2011 Apr
- Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis.
- Authors: Harty LC, Biniecka M, O'Sullivan J, Fox E, Mulhall K, Veale DJ, Fearon U
- Issue date: 2012 Apr
- Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint.
- Authors: Biniecka M, Kennedy A, Fearon U, Ng CT, Veale DJ, O'Sullivan JN
- Issue date: 2010 Jun
- Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis.
- Authors: Biniecka M, Connolly M, Gao W, Ng CT, Balogh E, Gogarty M, Santos L, Murphy E, Brayden D, Veale DJ, Fearon U
- Issue date: 2014 Dec